Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

This study has been completed.
Sponsor:
Collaborators:
German Federal Ministry of Education and Research
B. Braun Melsungen AG
Novo Nordisk A/S
HemoCue Gmbh, Großostheim, Germany
Information provided by:
German Competence Network Sepsis
ClinicalTrials.gov Identifier:
NCT00135473
First received: August 24, 2005
Last updated: February 10, 2016
Last verified: February 2016